181 related articles for article (PubMed ID: 16287870)
1. Impaired retinoic acid (RA) signal leads to RARbeta2 epigenetic silencing and RA resistance.
Ren M; Pozzi S; Bistulfi G; Somenzi G; Rossetti S; Sacchi N
Mol Cell Biol; 2005 Dec; 25(23):10591-603. PubMed ID: 16287870
[TBL] [Abstract][Full Text] [Related]
2. RAR-mediated epigenetic control of the cytochrome P450 Cyp26a1 in embryocarcinoma cells.
Pozzi S; Rossetti S; Bistulfi G; Sacchi N
Oncogene; 2006 Mar; 25(9):1400-7. PubMed ID: 16261163
[TBL] [Abstract][Full Text] [Related]
3. A repressive epigenetic domino effect confers susceptibility to breast epithelial cell transformation: implications for predicting breast cancer risk.
Bistulfi G; Pozzi S; Ren M; Rossetti S; Sacchi N
Cancer Res; 2006 Nov; 66(21):10308-14. PubMed ID: 17079450
[TBL] [Abstract][Full Text] [Related]
4. Derangement of a factor upstream of RARalpha triggers the repression of a pleiotropic epigenetic network.
Corlazzoli F; Rossetti S; Bistulfi G; Ren M; Sacchi N
PLoS One; 2009; 4(1):e4305. PubMed ID: 19173001
[TBL] [Abstract][Full Text] [Related]
5. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells.
Sirchia SM; Ferguson AT; Sironi E; Subramanyan S; Orlandi R; Sukumar S; Sacchi N
Oncogene; 2000 Mar; 19(12):1556-63. PubMed ID: 10734315
[TBL] [Abstract][Full Text] [Related]
6. Disruption of retinoic acid receptor alpha reveals the growth promoter face of retinoic acid.
Somenzi G; Sala G; Rossetti S; Ren M; Ghidoni R; Sacchi N
PLoS One; 2007 Sep; 2(9):e836. PubMed ID: 17786207
[TBL] [Abstract][Full Text] [Related]
7. The endogenous retinoid metabolite S-4-oxo-9-cis-13,14-dihydro-retinoic acid activates retinoic acid receptor signalling both in vitro and in vivo.
Schuchardt JP; Wahlström D; Rüegg J; Giese N; Stefan M; Hopf H; Pongratz I; Håkansson H; Eichele G; Pettersson K; Nau H
FEBS J; 2009 Jun; 276(11):3043-59. PubMed ID: 19490107
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic modulation of retinoic acid receptor beta2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinoma.
Wang XF; Qian DZ; Ren M; Kato Y; Wei Y; Zhang L; Fansler Z; Clark D; Nakanishi O; Pili R
Clin Cancer Res; 2005 May; 11(9):3535-42. PubMed ID: 15867257
[TBL] [Abstract][Full Text] [Related]
9. Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer.
Sirchia SM; Ren M; Pili R; Sironi E; Somenzi G; Ghidoni R; Toma S; Nicolò G; Sacchi N
Cancer Res; 2002 May; 62(9):2455-61. PubMed ID: 11980632
[TBL] [Abstract][Full Text] [Related]
10. PML-RARalpha and AML1-ETO translocations are rarely associated with methylation of the RARbeta2 promoter.
Tabe Y; Konopleva M; Kondo Y; Contractor R; Jin L; Ruvolo V; Tsutsumi-Ishii Y; Miyake K; Miyake N; Ohsaka A; Nagaoka I; Issa JP; Andreeff M
Ann Hematol; 2006 Oct; 85(10):689-704. PubMed ID: 16832676
[TBL] [Abstract][Full Text] [Related]
11. Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia.
Fazi F; Zardo G; Gelmetti V; Travaglini L; Ciolfi A; Di Croce L; Rosa A; Bozzoni I; Grignani F; Lo-Coco F; Pelicci PG; Nervi C
Blood; 2007 May; 109(10):4432-40. PubMed ID: 17244680
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid signaling biomarkers after treatment with retinoic acid and retinoic acid receptor alpha antagonist (Ro 41-5253) in canine testis: an in vitro organ culture study.
Kasimanickam VR; Kasimanickam RK
Theriogenology; 2013 Jan; 79(1):10-6. PubMed ID: 23102850
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells.
Cras A; Darsin-Bettinger D; Balitrand N; Cassinat B; Soulié A; Toubert ME; Delva L; Chomienne C
Oncogene; 2007 Jun; 26(27):4018-24. PubMed ID: 17213810
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation associated with polycomb repression in retinoic acid receptor β silencing.
Moison C; Senamaud-Beaufort C; Fourrière L; Champion C; Ceccaldi A; Lacomme S; Daunay A; Tost J; Arimondo PB; Guieysse-Peugeot AL
FASEB J; 2013 Apr; 27(4):1468-78. PubMed ID: 23299856
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivo.
Fazi F; Travaglini L; Carotti D; Palitti F; Diverio D; Alcalay M; McNamara S; Miller WH; Lo Coco F; Pelicci PG; Nervi C
Oncogene; 2005 Mar; 24(11):1820-30. PubMed ID: 15688037
[TBL] [Abstract][Full Text] [Related]
16. Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells.
Arapshian A; Kuppumbatti YS; Mira-y-Lopez R
Oncogene; 2000 Aug; 19(35):4066-70. PubMed ID: 10962564
[TBL] [Abstract][Full Text] [Related]
17. Valproic acid, in combination with all-trans retinoic acid and 5-aza-2'-deoxycytidine, restores expression of silenced RARbeta2 in breast cancer cells.
Mongan NP; Gudas LJ
Mol Cancer Ther; 2005 Mar; 4(3):477-86. PubMed ID: 15767557
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic priming of AML blasts for all-trans retinoic acid-induced differentiation by the HDAC class-I selective inhibitor entinostat.
Blagitko-Dorfs N; Jiang Y; Duque-Afonso J; Hiller J; Yalcin A; Greve G; Abdelkarim M; Hackanson B; Lübbert M
PLoS One; 2013; 8(10):e75258. PubMed ID: 24116031
[TBL] [Abstract][Full Text] [Related]
19. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
[TBL] [Abstract][Full Text] [Related]
20. Btg2 enhances retinoic acid-induced differentiation by modulating histone H4 methylation and acetylation.
Passeri D; Marcucci A; Rizzo G; Billi M; Panigada M; Leonardi L; Tirone F; Grignani F
Mol Cell Biol; 2006 Jul; 26(13):5023-32. PubMed ID: 16782888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
